EWA
BIIB icon

Evolution Wealth Advisors’s Biogen BIIB Stock Holding History

Evolution Wealth Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-120
Closed -$34K – 209
2021
Q3 		$34K Buy
120
+59
+97% +$19.3K 0.01% 252
2021
Q2 		$21K Buy
61
+35
+135% +$10.6K ﹤0.01% 299
2021
Q1 		$7K Hold
26
– – ﹤0.01% 471
2020
Q4 		$6K Hold
26
– – ﹤0.01% 412
2020
Q3 		$7K Hold
26
– – ﹤0.01% 388
2020
Q2 		$7K Buy
+26
New +$7.82K ﹤0.01% 321
2020
Q1 		– Sell
-28
Closed -$8K – 348
2019
Q4 		$8K Buy
28
+2
+8% +$555 ﹤0.01% 327
2019
Q3 		$6K Hold
26
– – ﹤0.01% 244
2019
Q2 		$6K Buy
+26
New +$6K ﹤0.01% 228

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Evolution Wealth Advisors's BIIB Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Biogen (BIIB) in Q4 2021, closing a stake of 120 shares — an estimated $34K sold.

Evolution Wealth Advisors first reported a position in BIIB in Q2 2019 and held it in 9 quarters. The position peaked at $34K in Q3 2021. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 120 Biogen shares in Q4 2021, an estimated $34K.
  • Evolution Wealth Advisors first reported a position in Biogen in Q2 2019 and held it in 9 quarters.
  • Evolution Wealth Advisors's Biogen position peaked at $34K in Q3 2021.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.